←
Jo Robson465 posts
Jo Robson avatar

Jo Robson

@Robsonjo4

Rheumatology doctor and researcher with an interest in patient reported outcomes and impact of rare rheumatic diseases- Vasculitis and SLE

◷ Joined May 2016▧ 11 Photos and videos
Dr. John Cush avatar
⟳ Jo Robson retweeted
Dr. John Cush@RheumNow·21 Apr 2025

Avacopan Versus Prednisone Taper in Patients With ANCA-Associated Vasculitis Without Kidney Involvement in a Phase 3 Trial Sponsored by Amgen buff.ly/kIHOgfh

Post attachment
Association of Women in Rheumatology avatar
⟳ Jo Robson retweeted
Association of Women in Rheumatology@AWIRGROUP·17 Feb 2025

Clinical trial diversity is not optional—it’s critical. As Dr. Gail Kerr, AWIR’s Director of Clinical Research, emphasizes: “Diversity in clinical trials is essential to understanding how various treatment approaches work in patients from different gene pools, backgrounds, and environments. When research subjects don’t reflect the populations a treatment is designed for, it undermines the quality of care for both patients and physicians, and threatens our ability to practice high-quality medicine.” The ripple effects of this extend beyond underrepresentation into: 1️⃣ Limited understanding of disease subtype and variations. 2️⃣ Inappropriate treatment and management strategies. 3️⃣ Suboptimal care for vulnerable populations. 4️⃣ Increasing disparities and mistrust among underserved communities. AWIR is committed to advancing equity through research that addresses these gaps and improves outcomes for all patients. Learn how we’re tackling these challenges: bit.ly/4gEX2eE #DiversityInResearch #ClinicalTrialsMatter #HealthEquity #AWIRLeadership

Post attachment
ZoiAn avatar
⟳ Jo Robson retweeted
ZoiAn@ZoiAn2·10 Dec 2024

One small step towards the right direction. Thank you!

It was great to see the Minister for Public Health and Prevention @GwynneMP raising the importance of specialised networks for delivering high-quality care and treatment for RAIRDs in Westminster Hall today #RAIRDaware

1:12
OMERACT avatar
⟳ Jo Robson retweeted
OMERACT@OMERACT·10 Dec 2024

📢 Join us for our Monthly Town Hall featuring the new PRISMA-COSMIN Guideline for reporting systematic reviews of Outcome Measurement Instruments (OMIs)! 🗓️ Dec 17, 2024, 8 AM EST 🔹 With experts Ellen Elsman & Martin Offringa. Review the guideline & video: lab.research.sickkids.ca/enr… 🔗 Zoom link: us06web.zoom.us/j/8235556102… #OMERACT #SystematicReviews #PRISMACOSMINOMI

Lupus Europe avatar
⟳ Jo Robson retweeted
Lupus Europe@LupusEurope·9 Dec 2024

😃Yes! This month's theme is adherence! 💎Adherence is one of the cornerstones of🔝 #lupus management, which requires a comprehensive & multifaceted approach to address the diverse aspects of the disease. 💪A significant part of the journey to #KickLupus lies within our grasp

Post attachment
ZoiAn avatar
⟳ Jo Robson retweeted
ZoiAn@ZoiAn2·6 Dec 2024

A brilliant opportunity to learn and then share awareness of rare rheumatic diseases. Thank you for the opportunity to make people with RAIRDs more visible and drive the improvement of care @RAIRDA_org @LukePollard @UKParliament #vasculitis #rarediseases

I’m proud to have tabled a Westminster Hall debate on rare autoimmune rheumatic diseases (RAIRDs) on Tuesday 10th December at 9:30am. A vital opportunity to raise awareness and support the over 170,000 people living with RAIRDs in the UK @RAIRDA_org #RAIRDaware #HealthDebate

RAIRDA avatar
⟳ Jo Robson retweeted
RAIRDA@RAIRDA_org·6 Dec 2024

Many thanks Jim - this debate will be a brilliant opportunity to raise awareness of the need for improved care and treatment for RAIRDs @LUPUSUK @WeAreSRUK @vascuk @ZoiAn2 @FarrSue01 @SjogrensUK

I’m proud to have tabled a Westminster Hall debate on rare autoimmune rheumatic diseases (RAIRDs) on Tuesday 10th December at 9:30am. A vital opportunity to raise awareness and support the over 170,000 people living with RAIRDs in the UK @RAIRDA_org #RAIRDaware #HealthDebate

Dr Alice Berry avatar
⟳ Jo Robson retweeted
Dr Alice Berry@Alicebez123·22 Oct 2024

Highlighting inequities across MSK pathways - Supporting People With Musculoskeletal Conditions From Underserved Communities in the United Kingdom to Engage With Physical Activity: A Realist Synthesis and Q-Methodology Study doi.org/10.1123/jpah.2024-01…